[Elsevier]
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer
AuthorsㄩN.C. Turner; C. Swift; B. Jenkins; L. Kilburn; M. Coakley; M. Beaney; L. Fox; K. Goddard; I. Garcia-Murillas; P. Proszek; P. Hall; C. Harper-Wynne; T. Hickish; S. Kernaghan; I.R. Macpherson; A.F.C. Okines; C. Palmieri; S. Perry; K. Randle; C. Snowdon; H. Stobart; A.M. Wardley; D. Wheatley; S. Waters; M.C. Winter; M. Hubank; S.D. Allen; J.M. Bliss; S. Chan; A. Armstrong; F. Raja; P. Schmid; A. Tutt; R. Roux; S. Cleator